It's A Bad Day For Biotechs
October 26, 2017 at 10:30 AM EDT
Biotech stocks are off to a rough start on Thursday, especially Celgene Corporation (NASDAQ: CELG), as shares plummeted to a new 52-week ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.